4

PRIMARY DOCUMENT

Company: AMICUS THERAPEUTICS, INC.
Filed: February 19, 2019
Period of Report: February 12, 2019
Accession Number: 0001012975-19-000185

View Document ↗ View on SEC.gov ↗